New Approaches to the Treatment of Chronic Hepatitis B

The currently recommended treatment for chronic hepatitis B virus (HBV) infection achieves only viral suppression whilst on therapy, but rarely hepatitis B surface antigen (HBsAg) loss. The ultimate therapeutic endpoint is the combination of HBsAg loss, inhibition of new hepatocyte infection, elimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexopoulou, Alexandra, Vasilieva, Larisa, Karayiannis, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601587/
https://www.ncbi.nlm.nih.gov/pubmed/33019573
http://dx.doi.org/10.3390/jcm9103187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601587/
https://www.ncbi.nlm.nih.gov/pubmed/33019573
http://dx.doi.org/10.3390/jcm9103187

Ejemplares similares